Literature DB >> 34224262

Mortality Among Persons Entering HIV Care Compared With the General U.S. Population : An Observational Study.

Jessie K Edwards1, Stephen R Cole1, Tiffany L Breger1, Jacqueline E Rudolph2, Lindsey M Filiatreau1, Kate Buchacz3, Elizabeth Humes4, Peter F Rebeiro5, Gypsyamber D'Souza4, M John Gill6, Michael J Silverberg7, W Christopher Mathews8, Michael A Horberg9, Jennifer Thorne10, H Irene Hall3, Amy Justice11, Vincent C Marconi2, Viviane D Lima12, Ronald J Bosch13, Timothy R Sterling14, Keri N Althoff4, Richard D Moore10, Michael Saag15, Joseph J Eron1.   

Abstract

BACKGROUND: Understanding advances in the care and treatment of adults with HIV as well as remaining gaps requires comparing differences in mortality between persons entering care for HIV and the general population.
OBJECTIVE: To assess the extent to which mortality among persons entering HIV care in the United States is elevated over mortality among matched persons in the general U.S. population and trends in this difference over time.
DESIGN: Observational cohort study.
SETTING: Thirteen sites from the U.S. North American AIDS Cohort Collaboration on Research and Design. PARTICIPANTS: 82 766 adults entering HIV clinical care between 1999 and 2017 and a subset of the U.S. population matched on calendar time, age, sex, race/ethnicity, and county using U.S. mortality and population data compiled by the National Center for Health Statistics. MEASUREMENTS: Five-year all-cause mortality, estimated using the Kaplan-Meier estimator of the survival function.
RESULTS: Overall 5-year mortality among persons entering HIV care was 10.6%, and mortality among the matched U.S. population was 2.9%, for a difference of 7.7 (95% CI, 7.4 to 7.9) percentage points. This difference decreased over time, from 11.1 percentage points among those entering care between 1999 and 2004 to 2.7 percentage points among those entering care between 2011 and 2017. LIMITATION: Matching on available covariates may have failed to account for differences in mortality that were due to sociodemographic factors rather than consequences of HIV infection and other modifiable factors.
CONCLUSION: Mortality among persons entering HIV care decreased dramatically between 1999 and 2017, although those entering care remained at modestly higher risk for death in the years after starting care than comparable persons in the general U.S. population. PRIMARY FUNDING SOURCE: National Institutes of Health.

Entities:  

Mesh:

Year:  2021        PMID: 34224262      PMCID: PMC8453103          DOI: 10.7326/M21-0065

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  54 in total

Review 1.  HIV infection, inflammation, immunosenescence, and aging.

Authors:  Steven G Deeks
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

2.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

3.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Authors:  Michael J Silverberg; Bryan Lau; Chad J Achenbach; Yuezhou Jing; Keri N Althoff; Gypsyamber D'Souza; Eric A Engels; Nancy A Hessol; John T Brooks; Ann N Burchell; M John Gill; James J Goedert; Robert Hogg; Michael A Horberg; Gregory D Kirk; Mari M Kitahata; Philip T Korthuis; William C Mathews; Angel Mayor; Sharada P Modur; Sonia Napravnik; Richard M Novak; Pragna Patel; Anita R Rachlis; Timothy R Sterling; James H Willig; Amy C Justice; Richard D Moore; Robert Dubrow
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

Review 4.  Cigarette smoking in the HIV-infected population.

Authors:  Shiva Rahmanian; Mary Ellen Wewers; Susan Koletar; Nancy Reynolds; Amy Ferketich; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2011-06

5.  Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Authors:  Keri N Althoff; Kelly A Gebo; Richard D Moore; Cynthia M Boyd; Amy C Justice; Cherise Wong; Gregory M Lucas; Marina B Klein; Mari M Kitahata; Heidi Crane; Michael J Silverberg; M John Gill; William Christopher Mathews; Robert Dubrow; Michael A Horberg; Charles S Rabkin; Daniel B Klein; Vincent Lo Re; Timothy R Sterling; Fidel A Desir; Kenneth Lichtenstein; James Willig; Anita R Rachlis; Gregory D Kirk; Kathryn Anastos; Frank J Palella; Jennifer E Thorne; Joseph Eron; Lisa P Jacobson; Sonia Napravnik; Chad Achenbach; Angel M Mayor; Pragna Patel; Kate Buchacz; Yuezhou Jing; Stephen J Gange
Journal:  Lancet HIV       Date:  2019-01-22       Impact factor: 12.767

6.  Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.

Authors:  Bonaventura Clotet; Judith Feinberg; Jan van Lunzen; Marie-Aude Khuong-Josses; Andrea Antinori; Irina Dumitru; Vadim Pokrovskiy; Jan Fehr; Roberto Ortiz; Michael Saag; Julia Harris; Clare Brennan; Tamio Fujiwara; Sherene Min
Journal:  Lancet       Date:  2014-04-01       Impact factor: 79.321

7.  Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults.

Authors:  Keri N Althoff; Kathleen A McGinnis; Christina M Wyatt; Matthew S Freiberg; Cynthia Gilbert; Krisann K Oursler; David Rimland; Maria C Rodriguez-Barradas; Robert Dubrow; Lesley S Park; Melissa Skanderson; Meredith S Shiels; Stephen J Gange; Kelly A Gebo; Amy C Justice
Journal:  Clin Infect Dis       Date:  2014-10-30       Impact factor: 9.079

8.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

9.  Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.

Authors: 
Journal:  Clin Infect Dis       Date:  2018-03-05       Impact factor: 9.079

10.  Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.

Authors:  Win Min Han; Lalita Wattanachanya; Tanakorn Apornpong; Jureeporn Jantrapakde; Anchalee Avihingsanon; Stephen J Kerr; Nipat Teeratakulpisarn; Tanate Jadwattanakul; Tawatchai Chaiwatanarat; Patinut Buranasupkajorn; Reshmie Ramautarsing; Nittaya Phanuphak; Sarat Sunthornyothin; Kiat Ruxrungtham; Praphan Phanuphak
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.240

View more
  4 in total

Review 1.  SARS-CoV-2 infection and coronavirus disease 2019 severity in persons with HIV on antiretroviral treatment.

Authors:  Julia Del Amo; Rosa Polo; Santiago Moreno; Inma Jarrín; Miguel A Hernán
Journal:  AIDS       Date:  2022-02-01       Impact factor: 4.177

2.  Five-Year Mortality for Adults Entering Human Immunodeficiency Virus Care Under Universal Early Treatment Compared With the General US Population.

Authors:  Jessie K Edwards; Stephen R Cole; Tiffany L Breger; Lindsey M Filiatreau; Lauren Zalla; Grace E Mulholland; Michael A Horberg; Michael J Silverberg; M John Gill; Peter F Rebeiro; Jennifer E Thorne; Parastu Kasaie; Vincent C Marconi; Timothy R Sterling; Keri N Althoff; Richard D Moore; Joseph J Eron
Journal:  Clin Infect Dis       Date:  2022-09-14       Impact factor: 20.999

3.  Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.

Authors:  Jennifer Beecker; Curtis Cooper; Mark G Kirchhof; Anton L Pozniak; Juergen K Rockstroh; Kim A Papp; Jan P Dutz; Melinda J Gooderham; Robert Gniadecki; Chih-Ho Hong; Charles W Lynde; Catherine Maari; Yves Poulin; Ronald B Vender; Sharon L Walmsley
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-21

4.  Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study.

Authors:  Raquel Martin-Iguacel; Juliana Reyes-Urueña; Andreu Bruguera; Jordi Aceitón; Yesika Díaz; Sergio Moreno-Fornés; Pere Domingo; Joaquín Burgos-Cibrian; Juan Manuel Tiraboschi; Isik Somuncu Johansen; Hortensia Álvarez; Josep M Miró; Jordi Casabona; Josep M Llibre
Journal:  EClinicalMedicine       Date:  2022-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.